Literature DB >> 30589921

Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer.

Zachery R Reichert1, Joshua Urrutia2, Joshi J Alumkal2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30589921     DOI： 10.1001/jamaoncol.2018.5789

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  Study of PD-1 Customization and Autoimmune T Cells for Advanced Colorectal Cancer with High MSI Expression.

Authors:  Na Li; Xiaojie Zhang; Yinsong Zhang; Fang Yang; Fengju Zhou
Journal:  Contrast Media Mol Imaging       Date:  2022-07-31       Impact factor: 3.009

2.  Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.

Authors:  Pedro Barata; Neeraj Agarwal; Roberto Nussenzveig; Benjamin Gerendash; Ellen Jaeger; Whitley Hatton; Elisa Ledet; Brian Lewis; Jodi Layton; Hani Babiker; Alan Bryce; Rohan Garje; Cy Stein; Lesli Kiedrowski; Philip Saylor; Oliver Sartor
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.